Simpler tests could slash biosimilar costs, widen patient access

For many years, a debate has raged over how much proof is required for a manufacturer to prove that a given biosimilar will work as well as the original biologic

Aug 3, 2025 1

Simpler tests could slash biosimilar costs, widen patient access
For many years, a debate has raged over how much proof is required for a manufacturer to prove that a given biosimilar will work as well as the original biologic
Read More